Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1001/jamainternmed.2014.1371 http://scihub22266oqcxt.onion/10.1001/jamainternmed.2014.1371 C4124903!4124903!24796406     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 276.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 310.4 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JAMA+Intern+Med 2014 ; 174 (7): 1176-82 Nephropedia Template TP {{tp|p=24796406|t=2014. DISSEMINATING EVIDENCE FROM A LANDMARK TRIAL: CROSS-SECTIONAL ANALYSIS OF DESCRIPTIONS AND INTERPRETATIONS OF THE ACCORD-LIPID TRIAL IN THE NEWS AND BIOMEDICAL LITERATURE |pdf=|usr=}}{{24796406}} gab.com Text DISSEMINATING EVIDENCE FROM A LANDMARK TRIAL: CROSS-SECTIONAL ANALYSIS OF DESCRIPTIONS AND INTERPRETATIONS OF THE ACCORD-LIPID TRIAL IN THE NEWS AND BIOMEDICAL LITERATURE JO: JAMA Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=24796406 #FOAvip The lipid component of the Action to Control Cardiovascular Risk in Diabetes trial (ACCORD-Lipid) was a landmark, publicly-funded trial demonstrating that fenofibrate, when added to statin therapy, was not associated with improved cardiovascular outcomes among patients with diabetes. We performed a cross-sectional study of all articles describing results of ACCORD-Lipid in the news and biomedical literature in the 15 months following its publication. For articles published in biomedical journals, we determined whether there was an association between authors? conflict of interests (COI) and trial interpretation. We identified 67 news and 141 biomedical journal articles discussing ACCORD-Lipid. Approximately 30% of news and biomedical journal articles described fenofibrate as ineffective, whereas nearly 20% concluded it was effective. Among articles making a recommendation, approximately 50% of news and 67% of biomedical journal articles supported continued fibrate use. Authors with COI were more likely to describe fenofibrate as effective (27.1% vs. 8.9%; relative risk [RR]=3.03, 95% confidence interval [CI], 1.22?7.50; P=0.008) and to support continued fibrate use (77.4% vs. 45.8%; RR=1.69, 95% CI, 1.07?2.67; P=0.006). ACCORD-Lipid was described inconsistently in news and biomedical journal articles, possibly creating uncertainty among patients and physicians, and COI were associated with more favorable trial interpretation. Twit Text FOAVip DISSEMINATING EVIDENCE FROM A LANDMARK TRIAL: CROSS-SECTIONAL ANALYSIS OF DESCRIPTIONS AND INTERPRETATIONS OF THE ACCORD-LIPID TRIAL IN THE NEWS AND BIOMEDICAL LITERATURE ????JAMA Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=24796406 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24796406 #FOAvip English Wikipedia <ref>{{Cite pmid|24796406}}</ref> DISSEMINATING EVIDENCE FROM A LANDMARK TRIAL: CROSS-SECTIONAL ANALYSIS OF DESCRIPTIONS AND INTERPRETATIONS OF THE ACCORD-LIPID TRIAL IN THE NEWS AND BIOMEDICAL LITERATURE #MMPMID24796406 Downing NS; Cheng T; Krumholz HM; Shah ND; Ross JS JAMA Intern Med 2014[Jul]; 174 (7): 1176-82 PMID24796406show ga The lipid component of the Action to Control Cardiovascular Risk in Diabetes trial (ACCORD-Lipid) was a landmark, publicly-funded trial demonstrating that fenofibrate, when added to statin therapy, was not associated with improved cardiovascular outcomes among patients with diabetes. We performed a cross-sectional study of all articles describing results of ACCORD-Lipid in the news and biomedical literature in the 15 months following its publication. For articles published in biomedical journals, we determined whether there was an association between authors? conflict of interests (COI) and trial interpretation. We identified 67 news and 141 biomedical journal articles discussing ACCORD-Lipid. Approximately 30% of news and biomedical journal articles described fenofibrate as ineffective, whereas nearly 20% concluded it was effective. Among articles making a recommendation, approximately 50% of news and 67% of biomedical journal articles supported continued fibrate use. Authors with COI were more likely to describe fenofibrate as effective (27.1% vs. 8.9%; relative risk [RR]=3.03, 95% confidence interval [CI], 1.22?7.50; P=0.008) and to support continued fibrate use (77.4% vs. 45.8%; RR=1.69, 95% CI, 1.07?2.67; P=0.006). ACCORD-Lipid was described inconsistently in news and biomedical journal articles, possibly creating uncertainty among patients and physicians, and COI were associated with more favorable trial interpretation. äDISSEMINATING EVIDENCE FROM A LANDMARK TRIAL: CROSS-SECTIONAL ANALYSIS(epmc).pdf DeepDyve Pubget Overpricing